Insider · CIK 0001597186

Schoell Josef

Reports to the SEC for 1 company · SHELTON, CT

sec.gov

Transactions

Companies

Filings

CIK

0001597186

Forms 4 and 5

Insider transactions

14 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-07-26	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,000 sh	$2.25	+$9,000	50,000
2017-07-26	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,000 sh	—	—	0
2017-03-08	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+55K sh	—	—	55,000
2016-03-30	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+48K sh	—	—	48,000
2016-03-16	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+8,000 sh	$0.78	+$6,240	36,000
2016-03-16	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$0.85	+$8,500	46,000
2016-03-16	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−8,000 sh	—	—	0
2016-03-16	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	0
2015-08-18	TVRDTvardi Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+3,000 sh	$22.10	+$66.3K	28,000
2015-06-15	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2015-02-17	TVRDTvardi Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−15K sh	$10.96	−$164K	25,000
2014-08-14	TVRDTvardi Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+40K sh	$0.25	+$10K	40,000
2014-08-14	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−40K sh	—	—	0
2014-01-30	TVRDTvardi Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Jul 284
Schoell Josef0001209191-17-046598
SEC(opens sec.gov)
Mar 104
Cara Therapeutics, Inc.0001209191-17-019915
SEC(opens sec.gov)
Apr 14
Cara Therapeutics, Inc.0001209191-16-111753
SEC(opens sec.gov)
Mar 174
Cara Therapeutics, Inc.0001209191-16-109307
SEC(opens sec.gov)
Aug 194
Cara Therapeutics, Inc.0001209191-15-066966
SEC(opens sec.gov)
Jun 174
Cara Therapeutics, Inc.0001209191-15-054317
SEC(opens sec.gov)
Feb 194
Cara Therapeutics, Inc.0001209191-15-016219
SEC(opens sec.gov)
Aug 144
Cara Therapeutics, Inc.0001209191-14-052463
SEC(opens sec.gov)
Jan 314
Cara Therapeutics, Inc.0001209191-14-006229
SEC(opens sec.gov)

Companies

Tvardi Therapeutics, Inc.Chief Financial OfficerTVRD

Address

C/O CARA THERAPEUTICS, INC. 1 PARROTT DRIVE

SHELTON, CT, 06484